According the contract, Dutchess may sale of up to $5.0 million shares of Bioject’s common stock over a three year period.

Thanks to the agreement, BJCT may not only improve the low volatility of its stock. The company as well preconditions its fluent operations through ensuring regular cash flows.

The companies agreed, that Bioject Medical Technologies Inc. may in its discretion, sell newly-issued shares to Dutchess. BJCT has the right to receive advances, generally limited to $100 thousand.

Bioject Medical Technologies Inc. offers a portfolio of needle-free injection products to meet the varied needs of today’s healthcare environment. The company has been incorporated in 1985 with a main focus on developing needle-free injection technology.

The agreements sound like a natural follow up on the company’s Bieber Agreement, taking in consideration as well the  positive developments of OPMG during last three months.

The contracts are in unison with company’s willingness to make its flagship product named “Drive Safe” a next-generation software, with the most robust set of features and functions available today. Part of the compensation package are the performance bonuses. The CEO and the Chairman of OPMG will receive quarterly and annual performance bonuses, bound with company’s operational results. As stated by Options Media, the bonuses will be payable in cash or shares of common stock equal to 5% of the company’s earnings before interest, taxes, depreciation, and amortization (“EBITDA”) for the applicable period.

Several hours ago, Warner Bros. Entertainment announced to have signed a contract with You On Demand Media, the company’s joint venture in China. The deal will grant many Chinese the opportunity to enjoy watching first-class Hollywood films through You On Demand platform.

Not accidentally so, the Chairman and CEO of the company, Mr McMahon called the agreement “a historic milestone” for You On Demand. It is interesting to see whether this will also lead to a progress in the share price.

As a whole, the stock is going in the right direction. Throughout March and April, CBBD was traded between $0.04 and $0.06. Since then, the price gain has been significant. Yesterday, CBBD ended trading at $0.11 which is not far from the 52-week high of $0.13. The volume was around the average – 1M shares were turned over.

A week ago, another positive development was issued. You On Demand announced the completion of $11M private placement, which strengthened the corporation financially. It was also the main topic of the latest company’s 8K-filing on SEC. Now the company has additional funds at its disposal.

They are not excessive at all. The latest financial reports show not a very bright picture. A loss of $8.92 for 2010 and a $2.23M negative income for the first quarter of 2011 may serve as a proof of our conclusion.

Nevertheless, You On Demand has its grounds to anticipate the future with optimism, especially after the mentioned deal with Warner Bros. Entertainment.

Of course, there is no way you remain bored after the flood of announcements that Altitude pours onto investors each month. You are probably well acquainted with all the developments released by the corporation. So, it makes no much use to retell these now.

What is worth mentioning, is that the company is actively watching the battle around cannabis on the national level. It is hardy a coincidence that Altitude provided to investors so many comments and detailed information regarding the Federal Legislation directed toward legalizing cannabis. Organizations, like the National Cannabis Industry Association (NCIA) introduced several pro-marijuana bills in the House of Representatives about two weeks ago.

Perhaps, the corporation was somewhat disappointed when Arizona Governor, Jan Brewer, requested a delay in the implementation of the Arizona medical marijuana program. It was probably among the reasons that made Altitude acquire 50% of Sundance Hydroponics, a national retailer of horticulture equipment. The company’s CEO, Mr Cook, defines Hydroponics as “the most dependable equipment provider in the Colorado medical marijuana industry.”

The fight continues. Altitude will not get discouraged after the mentioned delay in Arizona’s dispensary application process. The fight, actually, started a long time ago. During the last months it is going on with a vengeance. This April, the company launched its attack on the Arizona market. Very soon, the corporation informed to have signed up three potential dispensary owners in Arizona who wished to open their own Altitude Organic Medicine dispensaries.

Unfortunately, we see no 8K filings made by the company on SEC.

Maybe, the shares need to rest a bit, to regain strength, before trying to attack new heights and to break new records. On the other hand, there is no guarantee the stock will start advancing again in the next days. The latest financial reports of the company reveal that Legend recorded a net loss of $0.11M for the first quarter of 2011, despite realizing revenue for the amount of $0.46M. Besides, the company had a working capital of just $17K as at Mar 31, 2011.

As we see, there is still what to be desired, regarding Legend’s financial state. Company’s managers have probably some tough work to do. The good thing is some of the job has already been finished. It was, in fact, finished last year. Legend began its expansion activities through the acquisition of new, strategically important claims.

In October, 2010, the company purchased eight oil and gas leases owned by Piqua Petro, Inc. and located in Kansas. The leases contain 1,040 acres of oil-producing land. After this, in March 2011, Legend acquired over 3,800 acres of undeveloped mineral leases situated in Divide County region in North Dakota.

All mentioned by far, makes it no easier to foretell whether the stock will be able to climb to new heights soon, or a downfall will ensue instead. We might take into consideration two other earlier released and positively looking company developments. They were the main topic of the latest 8K form, filed on SEC about one month ago.

We mean two press releases. One of them announcing that company information will be made available via Standard & Poor’s Market Access Program. The second one stating that Legend has begun the permitting process for the drilling of its development program on the producing leases in Piqua, Kansas. The company expects to drill three wells in this program and to “see new production soon after equipping of the wells is completed.”

Liberty is a corporation concentrated on the exploration of mineral deposits in the states of Arizona and Alaska. The assets in Alaska are held in the name of the company’s wholly owned subsidiary – Big Chunk Corp.

About two weeks ago, when Liberty received the first draft of the NI 43-101 technical report on the Tombstone Porphyry-Precious Metals Project, LBSR simply flew to the skies. In three sessions, the stock made a huge gain climbing 60% up – from $0.028 to $0.045.

What is even better, in the days to follow the stock went a bit higher and finished at $0.056 on Thursday. LBSR continues to remain in the overbought area. We shall see whether is has the potential to progress further up in the near future.

The latest financial statements, filed by the company, reveal not a very lovely picture. The reader can see total current assets of $1.1M and total current liabilities of $3.3M, which is an indication of a negative working capital. This implies it will be perhaps hard for LBSR to advance substantially in terms of price.

In addition, the reports show a large loss of $19.8M for the twelve months ended Jan. 31, 2011. The main part of it – $13.2M – came from settlement expenses.

As for Liberty’s 8K filing, we find one dated May 27, 2011. It concerns primarily an engagement letter agreement with McNicoll, Lewis & Vlak LLC (“MLV”). Under the deal, MLV agrees to provide certain exclusive and non-exclusive financial advisory services to the corporation. You can read the text of the agreement on this link.

The biggest news for NeoMedia Technologies came in the end of May when the company’s patents were re-examined and affirmed by the United States Patent and Trademark Office (PTO). This was a truly important victory for NeoMedia, as the present CEO, Mrs Laura Mariott, states in a recent interview.

The patent authorities in America ruled in favor of NeoMedia’s Barcode Lookup Patent. Company’s representatives now hope that the confirmation of a patent, challenged by reexamination twice in four years, “puts the issues of its validity to rest.”

To pay so much attention to this patent decision is not an accidental circumstance. We already outlined the significance of the news for the company. Besides, it triggered a real explosion in NeoMedia’s share price on the American OTC market in late May. NEOM went into a new orbit, climbing from $0.015 to $0.207 within two days, or by 1280%.

Now, the euphoria has come to its natural end. In June, the market cooled off and the shares began declining, to close yesterday at $0.048. Perhaps, investors were also cooled by the recent financial reports of NeoMedia – they reveal current assets of $600 thousand and current liabilities of $79 million.

The latest 8K filing was from June 3. It was dedicated to a debenture agreement with YA Global Investments, LP. Readers can find a summarize of all outstanding company’s debentures on this link.

In view of this, it is hardly very surprising to see the success which several companies, offering alternative products to the regular smokers, enjoy. Smokefree Innotec, Inc. (PINK:SFIO) is an eloquent example. In several consecutive recent announcements, the company did not miss the opportunity to enlighten the public about the high demand and the great interest towards its RE/AL e-cigarettes.

The e-cigarettes were offered through the SFIO website shopping cart and were entirely sold out in the end of May. Fortunately, they were quickly refilled with new shipments of RE/AL. Now customers continue to enjoy the benefits of using this product.

Perhaps some of the reasons that made Smokefree’s e-cigarettes such a hit lie in the advantages they offer, as revealed on the company’s website.

The success of RE/AL led to a natural progress in the share price too. The advance was more evident in mid-May when SFIO simply erupted on the American OTC market, gaining value on large volumes. However, Smokefree has not published any 8k-files on SEC, which raises some concerns and doubts about the company.

]]> http://www.8kfiling.com/smokefree-innotec-inc-pinksfio-enjoys-a-great-demand-of-its-products/feed 0 http://www.8kfiling.com/multicell-technologies-inc-otcmcet-anticipates-the-future-with-optimism http://www.8kfiling.com/multicell-technologies-inc-otcmcet-anticipates-the-future-with-optimism#comments Wed, 08 Jun 2011 04:21:35 +0000 nikolay http://www.8kfiling.com/?p=1118 Managers of MuliCell Technologies (OTC:MCET) certainly have their reasons to look at the future with optimism in the eyes. Especially when last week the United States Patent and Trademark Office (USPTO) issued U.S. Patent 7,935,528, to which MultiCell is the worldwide exclusive licensee.

The patent is related to the isolation and use of human liver stem cells to treat liver disease or inherited deficiencies of liver function.

The fabulous news made the shares explode. They flew to a 52-week high of $0.0245 on the last day of May. Immediately after that, the market cooled off, and MCET fell down significantly to close yesterday at $0.008.

The stock performance caught the attention of promoters too. The days, following the announcement, were full of stock alerts for MultiCell.

This progress comes in time for the company, whose financial condition cannot be classified as exactly flourishing. The latest 8-K filing was published a long time ago – back in last November. It was based on a press release, informing MuliCell was awarded $733K under U.S. Government’s therapeutic program.

It is not clear to what extent these funds were sufficient. The recent financial statements indicated that company’s current assets were less than its current liabilities, as a result of which there was a negative working capital of over $1M.

At the end of the last month, CLNO filed for SEC the resignation of Alexander Holtermann as company’s CEO and President. As stated by the company, he will pursue other interests and business opportunities, while remaining as a director of Cleantech. On this position, CLNO appointed Kenneth Bosket.

Last Monday, followed the next 8k filing of Cleantech Transit Inc. which was again referring to the above mentioned managers. It looked, like the company had done a mistake, making for the second time the same disclosure.

No, there was no a mistake. With the filing done last week, Cleantech Transit Inc. transmitted almost all its managerial power to Mr. Bosket.

As stated in company’s recent disclosure, the Board of Directors of CLNO appointed its President and CEO, Kenneth Bosket, as a director of the company also.

At the time of the filing done, Mr. Bosket had no a direct or indirect material interest in the company. There was no even material plan, contract or arrangements to which Mr. Bosket is a party or in which he participated.

This, which is known about Kenneth Bosket is that he is a president and CEO of Crown Equity Holdings Inc. (OTCBB: CRWE) and has been with Crown Equity since June, 2008.